
Myokinasib
CAS No. ——
Myokinasib( —— )
Catalog No. M17042 CAS No. ——
Myokinasib is a mixed-type, selective inhibitor of Myosin Light Chain Kinase 1 (MLCK1) with IC50 of 7.9 uM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameMyokinasib
-
NoteResearch use only, not for human use.
-
Brief DescriptionMyokinasib is a mixed-type, selective inhibitor of Myosin Light Chain Kinase 1 (MLCK1) with IC50 of 7.9 uM.
-
DescriptionMyokinasib is a mixed-type, selective inhibitor of Myosin Light Chain Kinase 1 (MLCK1) with IC50 of 7.9 uM, can bind to the free enzyme and the enzyme-substrate complex; Myokinasib inhibits only two additional kinases PLK2/3 with IC50 of 10.3/6.7 uM in a panel of 25 kinases, does not bind to the Polo-box domain of PLK2 and PLK3; impairs cytokinesis, induces formation of multinucleated cells, and reduces phosphorylated myosin II light chain abundance on stress fibers, reduces phospho-S19-MLC protein levels in cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetMyosin
-
RecptorMyosin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight402.538
-
Molecular FormulaC26H30N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Nameethyl (6R,7R,8S,9R)-8-(2,6-dimethylphenyl)-6,7-dimethyl-6,7,8,10-tetrahydro-6,9-epiminocyclohepta[b]indole-9(5H)-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Schneidewind T, et al. Cell Chem Biol. 2018 Dec 11. pii: S2451-9456(18)30436-7.
molnova catalog



related products
-
Myokinasib
Myokinasib is a mixed-type, selective inhibitor of Myosin Light Chain Kinase 1 (MLCK1) with IC50 of 7.9 uM.
-
MS-444
MS-444 (BE-34776) is a smooth muscle myosin light chain kinase (MLCK) and HuR inhibitor with antitumor activity for triple-negative breast and colorectal cancer.
-
BHC
BHC (Myosin inhibitor BHC) is a small-molecule screen of skeletal muscle myosin inhibitor.